Goldman Sachs Group, Inc. (The) set a €82.00 ($96.47) price objective on Sanofi SA (EPA:SAN) in a research note released on Monday. The firm currently has a neutral rating on the stock.

A number of other equities analysts have also recently commented on SAN. J P Morgan Chase & Co set a €87.00 ($102.35) price target on shares of Sanofi SA and gave the stock a neutral rating in a research note on Tuesday, April 11th. Deutsche Bank AG set a €96.00 ($112.94) price target on shares of Sanofi SA and gave the stock a buy rating in a research note on Tuesday, April 11th. Kepler Capital Markets set a €92.00 ($108.24) price target on shares of Sanofi SA and gave the stock a buy rating in a research note on Wednesday, April 12th. Morgan Stanley set a €91.00 ($107.06) price target on shares of Sanofi SA and gave the stock a buy rating in a research note on Monday, April 24th. Finally, Berenberg Bank set a €92.00 ($108.24) price target on shares of Sanofi SA and gave the stock a buy rating in a research note on Friday, April 28th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and five have given a buy rating to the company’s stock. The company has a consensus rating of Hold and an average price target of €87.63 ($103.09).

Shares of Sanofi SA (EPA SAN) opened at 81.46 on Monday. The firm has a market cap of €102.29 billion and a price-to-earnings ratio of 11.36. Sanofi SA has a 52-week low of €62.50 and a 52-week high of €92.97. The company’s 50 day moving average is €25.48 and its 200 day moving average is €25.74.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/08/sanofi-sa-epasan-given-a-82-00-price-target-by-goldman-sachs-group-inc-the-analysts.html.

About Sanofi SA

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company’s segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.

Analyst Recommendations for Sanofi SA (EPA:SAN)

Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with MarketBeat.com's FREE daily email newsletter.